Clinical outcomes and markers of treatment response in a randomized phase II study of androgen deprivation therapy with or without palbociclib in RB-intact metastatic hormone-sensitive prostate cancer (mHSPC).

被引：0

作者：

Palmbos, Phillip Lee

Tomlins, Scott A.

Daignault, Stephanie

Agarwal, Neeraj

Twardowski, Przemyslaw

Morgans, Alicia K.

Kelly, William Kevin

Arora, Vivek

Antonarakis, Emmanuel S.

Siddiqui, Javed

Robinson, Dan

Knudsen, Karen E.

Chinnaiyan, Arul

Hussain, Maha H. A.

机构：

[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Ann Arbor, MI 48109 USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[4] City Hope Natl Med Ctr, Duarte, CA USA

[5] Northwestern Univ, Chicago, IL 60611 USA

[6] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA

[7] Washington Univ, St Louis, MO 63110 USA

[8] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[9] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA

[10] Univ Michigan, Ctr Translat Pathol, Ann Arbor, MI 48109 USA

[11] Sidney Kimmel Canc Ctr Jefferson Hlth, Philadelphia, PA USA

[12] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5573

引用

页数：2